New South Wales Health Pathology, Prince of Wales Hospital, Randwick, Sydney 2031, Australia.
Discipline of Child and Adolescent Health, University of Sydney, Sydney 2031, Australia.
Genes (Basel). 2020 Apr 3;11(4):391. doi: 10.3390/genes11040391.
Pathogenic variants in , encoding epithelial cadherin (E-cadherin), have been implicated in hereditary diffuse gastric cancer (HDGC), lobular breast cancer, and both syndromic and non-syndromic cleft lip/palate (CL/P). Despite the large number of mutations described, the nature of the phenotypic consequence of such mutations is currently not able to be predicted, creating significant challenges for genetic counselling. This study collates the phenotype and molecular data for available variants that have been classified, using the American College of Medical Genetics and Genomics criteria, as at least 'likely pathogenic', and correlates their molecular and structural characteristics to phenotype. We demonstrate that variant type and location differ between HDGC and CL/P, and that there is clustering of CL/P variants within linker regions between the extracellular domains of the cadherin protein. While these differences do not provide for exact prediction of the phenotype for a given mutation, they may contribute to more accurate assessments of risk for HDGC or CL/P for individuals with specific variants.
编码上皮钙黏蛋白(E-钙黏蛋白)的 中的致病性变异与遗传性弥漫性胃癌(HDGC)、乳腺小叶癌以及综合征性和非综合征性唇腭裂(CL/P)有关。尽管已经描述了大量的 突变,但这些突变的表型后果的性质目前还无法预测,这给遗传咨询带来了重大挑战。本研究汇集了使用美国医学遗传学与基因组学学院标准分类为至少“可能致病性”的可用 变异的表型和分子数据,并将其分子和结构特征与表型相关联。我们表明,HDGC 和 CL/P 之间的 变异类型和位置不同,并且在钙黏蛋白蛋白的细胞外结构域之间的连接区存在 CL/P 变异的聚类。虽然这些差异不能为特定突变的表型提供准确的预测,但它们可能有助于对具有特定 变异的个体的 HDGC 或 CL/P 风险进行更准确的评估。
Am J Med Genet A. 2020-7
J Med Genet. 2019-1-19
Eur J Med Genet. 2021-10
Cell Commun Signal. 2024-2-27
Nat Genet. 2023-4
Front Genet. 2022-9-28
Biology (Basel). 2022-1-18
Genet Test Mol Biomarkers. 2019-11
Cancers (Basel). 2019-9-11
Nucleic Acids Res. 2019-1-8
Nucleic Acids Res. 2019-1-8